Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 reinfection and implications for vaccine development
Firzan Nainu, Rufika S. Abidin, Muh. Akbar Bahar, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 12, pp. 3061-3073
Open Access | Times Cited: 71

Showing 26-50 of 71 citing articles:

Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management
Vivek P. Chavda, Aayushi Patel, Lalitkumar K. Vora, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 10, pp. 1395-1403
Closed Access | Times Cited: 13
Modeling SARS‐CoV‐2 True Infections in Catalonia through a Digital Twin
Pau Fonseca i Casas, Joan Garcia i Subirana, Víctor García i Carrasco
Advanced Theory and Simulations (2023) Vol. 6, Iss. 7
Open Access | Times Cited: 7
Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness
Somayeh Yazdanparast, Mehdi Bakhtiyaridovvombaygi, Fatemeh Mikanik, et al.
Life Sciences (2023) Vol. 328, pp. 121907-121907
Open Access | Times Cited: 7
Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection
Laura Sánchez-de Prada, Ana María Martínez-García, Belén González-Fernández, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial
Irene García-García, Enrique Seco-Meseguer, Pilar Ruíz-Seco, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 1139-1139
Open Access | Times Cited: 11
SARS‐CoV‐2 Omicron (B.1.1.529) infection in rhesus macaques, hamsters, and BALB/c mice with severe lung histopathological damage
Wenhai Yu, Junbin Wang, Yun Yang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Open Access | Times Cited: 6
Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG
Mohd. Raeed Jamiruddin, Md. Ahsanul Haq, Kazuhito Tomizawa, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 2497-2506
Open Access | Times Cited: 14
Containment strategies for COVID-19 in India: lessons from the second wave
Purva Asrani, Keshav Tiwari, Mathew Suji Eapen, et al.
Expert Review of Anti-infective Therapy (2022) Vol. 20, Iss. 6, pp. 829-835
Closed Access | Times Cited: 10
A Comprehensive Overview of the Newly Emerged COVID-19 Pandemic: Features, Origin, Genomics, Epidemiology, Treatment, and Prevention
Md. Takim Sarker, Ahmed Khairul Hasan, Md. Oliullah Rafi, et al.
Biologics (2021) Vol. 1, Iss. 3, pp. 357-383
Open Access | Times Cited: 13
Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
A. Skwarek, Aleksandra Gąsecka, Miłosz Jaguszewski, et al.
Archives of Medical Science (2021) Vol. 19, Iss. 5, pp. 1410-1420
Open Access | Times Cited: 12
Inhibition of receptor‐binding domain—ACE2 interaction after two doses of Sinovac's CoronaVac or AstraZeneca/Oxford's AZD1222 SARS‐CoV‐2 vaccines
Valéria Oliveira Silva, Rosemeire Yamashiro, Cintia Mayumi Ahagon, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 3, pp. 1217-1223
Open Access | Times Cited: 12
Retracted: Clinical Characteristics and Risk Factors Associated with Severe Disease Progression among COVID‐19 Patients In Wad Medani Isolation Centers: A Multicenter Retrospective Cross‐Sectional Study
Mohammed Yousif Elnaeem Yousif, Mohammed Mahmmoud Fadelallah Eljack, Mazin S. Haroun, et al.
Health Science Reports (2022) Vol. 5, Iss. 2
Open Access | Times Cited: 8
The Antiviral Potential of a Natural Compound for COVID-19: A Review of the Current Findings
Zahra Jafari-Ardakan, Reza Arefnezhad, Fatemeh Rezaei‐Tazangi
Natural Product Communications (2024) Vol. 19, Iss. 10
Open Access | Times Cited: 1
Metabolic reprogramming and immune regulation in viral diseases
Goutham V. Ganesh, Kunka Mohanram Ramkumar
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Closed Access | Times Cited: 11
COVID-19 vaccination strategies depend on the underlying network of social interactions
Helena A. Saunders, Jean‐Marc Schwartz
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 11
A Critical Review on the Potency of Phytoconstituents in the Management of COVID-19
Kannan Raman, Kalirajan Rajagopal, Gomathi Swaminathan, et al.
Journal of Pure and Applied Microbiology (2023) Vol. 17, Iss. 3, pp. 1320-1340
Open Access | Times Cited: 2
Waning of SARS-CoV-2 Vaccine Effectiveness in COPD Patients: Lessons from the Delta Variant
Lőrinc Polivka, István Vályi‐Nagy, Zoltán Szekanecz, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1786-1786
Open Access | Times Cited: 2
Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials
Hui Yin Lim, Masita Arip, Abdul Al-Fattah Yahaya, et al.
Frontiers in Bioscience-Landmark (2021) Vol. 26, Iss. 11, pp. 1286-1286
Open Access | Times Cited: 6
Is vaccination necessary for COVID-19 patients? A retrospective cohort study investigating reinfection rates and symptomatology in a tertiary hospital
Ferhat Arslan, Burcu Isık Goren, Begümhan Baysal, et al.
Expert Review of Vaccines (2021) Vol. 21, Iss. 2, pp. 249-252
Closed Access | Times Cited: 6
Assessment of Attitudes, Main Concerns and Sources of Knowledge Regarding COVID-19 Vaccination in Poland in the Unvaccinated Individuals—A Nationwide Survey
Mateusz Babicki, Wojciech Malchrzak, Agnieszka Mastalerz–Migas
Vaccines (2022) Vol. 10, Iss. 3, pp. 381-381
Open Access | Times Cited: 4
Efficacy and Safety of Blood Derivative Therapy for Patients with COVID-19: A Systematic Review and Meta-Analysis
Zhangcheng Fei, Zhongsheng Chen, Xi Du, et al.
Transfusion Medicine and Hemotherapy (2022) Vol. 49, Iss. 6, pp. 388-400
Open Access | Times Cited: 4
Playing around the anaerobic threshold during COVID-19 pandemic: advantages and disadvantages of adding bouts of anaerobic work to aerobic activity in physical treatment of individuals with obesity
Alberto Salvadori, Paolo Fanari, Paolo Marzullo, et al.
Acta Diabetologica (2021) Vol. 58, Iss. 10, pp. 1329-1341
Open Access | Times Cited: 5
Epidemiological samplings for long-term HBM-studies during a pandemic situation – Experiences and lessons-learned, the German Environmental Specimen Bank during the COVID-19 pandemic
Martina Bartel-Steinbach, Till Weber, Markus Michel, et al.
Toxicology Letters (2024) Vol. 398, pp. 118-126
Open Access
Exploring the therapeutic potential of Thai medicinal plants: in vitro screening and in silico docking of phytoconstituents for novel anti-SARS-CoV-2 agents
Bussayarat Maikhunthod, Sukanya Chaipayang, Akanitt Jittmittraphap, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access
Development and Validation of a Highly Sensitive RT-qLAMP Assay for Rapid Detection of SARS-CoV-2: Methodological Aspects
F. Baba Mahmoudi, Davod Jafari, Seyedeh Mona Mousavi Esfahani, et al.
Molecular Biotechnology (2024)
Closed Access

Scroll to top